Christo H. van Niekerk, MD, FCPaed

Senior Medical Officer and BU-01 Medical Monitor
Qurient Co Ltd
Pretoria, Gauteng, South Africa

Disclosure information not submitted.

Presentation(s):

• 547 - An Open-label Multicenter Phase 2 Trial of Telacebec for Adults with Buruli ulcer: the TREAT-BU Trial

  Wednesday, October 22, 2025
  10:42 AM - 10:54 AM US ET